|
Customer News
Ambrx, Inc. chooses R&D Time software service
Ambrx
located in La Jolla, California, has subscribed to R&D Time software service to
collect, track and report project effort. Special emphasys will be put on tracking effort by collaborator.
Ambrx, Inc. is a biopharmaceutical company with a mission
to deliver breakthrough protein therapeutics.
Neurobiological Technologies, Inc.
fast tracks the use of R&D Logic Budgeting Software
NTI
located in Emeryville, California, has chosen R&D Logic budgeting software to
create the next corporate plan. Neurobiological Technologies, Inc. is a biotechnology
company engaged in the business of acquiring and developing central nervous system (CNS) related
drug candidates.
Tercica, Inc.
selects R&D Logic Software
Tercica, Inc.
located in Brisbane, California, has chosen R&D Logic software for
corporate planning, tracking and financial reporting. Tercica is a
biopharmaceutical company working to develop and commercialize
therapeutics for growth and other endocrine disorders.
Savient Pharmaceuticals
selects R&D Logic Software
Savient Pharmaceuticals
located in East Brunswick, New Jersey, has selected R&D Logic software for
corporate planning, tracking and financial reporting. Savient Pharmaceuticals is a specialty
biopharmaceutical company engaged in developing and distributing pharmaceutical
products that target unmet medical needs in both niche and broader markets.
Catalyst Biosciences
selects R&D Logic Software
Catalyst Biosciences
located in South San Francisco, California, has opted to use R&D Logic software to collect time effort,
and to track and report project resources. Catalyst Biosciences is a leading biotechnology
company focused on developing proteases as a therapeutic platform for inflammation,
cardiovascular, and angiogenesis-based disorders.
Via Pharmaceuticals, Inc.
selects R&D Logic Software
Via Pharmaceuticals, Inc.
located in San Francisco, California, has selected R&D Logic enterprise software for financial planning
and analysis, consolidated reporting as well as for project effort collection and project portfolio
specific planning and monitoring. VIA is a biotechnology company focused on the development of compounds for
the treatment of cardiovascular disease.
Kalypsys, Inc.
selects R&D Logic Software
Kalypsys, Inc.
located in San Diego, California, has chosen R&D Logic software for
tracking and planning project resources and time effort. Kalypsys is a clinical stage pharmaceutical
company that is advancing the way drugs are discovered and developing breakthrough
therapies for some of the world's most widespread diseases including
cardiovascular/metabolic diseases, pain/inflammation and oncology.
FivePríme Therapeutics, Inc.
selects R&D Logic Software
Five Príme Therapeutics, Inc.
located in San Francisco, California, has selected R&D Logic software for
planning, tracking and time collection. FivePríme Therapeutics, Inc. is a pre-clinical stage biotech company
discovering and developing innovative protein and antibody therapeutics.
FivePríme is developing treatments for cancer and diabetes
and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.
Macroflux Corporation
selects R&D Logic Software
Macroflux Corporation
located in Mountain View, California, has opted to use the R&D Logic complete enterprise solution for
planning, tracking and time collection. Macroflux is a spin-out of ALZA Corporation (a subsidiary of Johnson
& Johnson). The Macroflux system is based on a small patch and applicator that is intended to provide a needle-free
solution for transdermal delivery of therapeutic proteins, peptides and vaccines. It is designed to combine
painless and convenient drug administration with rapid delivery and high bioavailability.
SGX Pharmaceuticals
selects R&D Logic Software for Planning and Tracking
SGX Pharmaceuticals Inc.
located in San Diego, California, has decided to use R&D Logic enterprise solution to support
FP&A company-wide processes. SGX Pharmaceuticals is a biotechnology company focused on the discovery,
development and commercialization of innovative cancer therapeutics.
Alnylam Pharmaceuticals
selects R&D Logic Software
Alnylam Pharmaceuticals Inc.
located in Cambridge, Massachusetts, has selected R&D Manage, R&D Time and R&D P&L
to support corporate strategic and operational planning as well as monthly tracking and analysis.
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on
a breakthrough in biology known as RNA interference, or RNAi.
Momenta Pharmaceuticals
selects R&D Logic Enterprise Solution
Momenta Pharmaceuticals Inc.
located in Cambridge, Massachusetts, has selected R&D Logic suite of software to
support planning, tracking, time collection and corporate analysis and reporting.
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis
and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs,
the development of novel drugs, and the discovery of new biological processes.
InterMune
chooses R&D Resource software
InterMune Inc.
located in Brisbane, California, has opted to use R&D Logic software to support Project Time collection
as well Time off collection and tracking, our latest addition to the enterprise solution. In addition, InterMune will be using software capabilities
to track and analyze resource utilization by project and program. InterMune is a publicly traded biotech company
focused on developing and commercializing innovative therapies in hepatology and pulmonology.
Titan Pharmaceuticals
chooses R&D Logic suite for Planning and Tracking
Titan Pharmaceuticals Inc.
located in South San Francisco, California, has selected the full R&D Logic suite of software
to support corporate planning, tracking, time collection and corporate reporting and analysis.
Titan is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders,
cardiovascular disease, bone disease and other disorders.
Valentis selects R&D Time
solution for tracking actual project effort
Valentis, Inc.
located in Burlingame, California, has selected R&D Time to replace in-house
time and attendance system and complete the R&D Logic enterprise suite that has been in used
for the past four years.
Valentis is a biotechnology company engaged in the development of innovative products for peripheral
arterial disease (PAD), a large and unsatisfied market.
Avidia selects R&D Logic
enterprise solution for planning and tracking
Avidia, Inc.
located in Mountain View, California, has selected R&D Manage, R&D Time and R&D P&L
to support corporate strategic and operational planning as well as monthly tracking and analysis.
Avidia is focused on developing a new class of therapeutic proteins for treatments in areas including
autoimmunity, inflammation and oncology.
NeuroMolecular selects R&D Logic
solution for corporate planning and tracking
NeuroMolecular Pharmaceuticals, Inc.
located in Emeryville, California has selected R&D
Manage and P&L platform to support project portfolio and corporate
planning and tracking business processes. NeuroMolecular Pharmaceuticals is developing and
commercializing superior neuroprotective medicines for the treatment of central nervous
system (CNS) disorders.
EPIX Pharmaceuticals selects R&D
Time as the new company time & attendance solution
Epix, who currently uses R&D Manage
for their corporate budgeting and tracking, has decided to expand their usage of R&D
Logic products and include R&D Time, a software tool specifically developed
to collect project efforts by employee. R&D Time will replace the current time collection system.
Avigen selects R&D Logic
solution to plan and track corporate financials and resources
Avigen, Inc. located in Alameda, California has selected R&D
Manage and R&D Time software to support corporate and project
planning and tracking activities. Avigen (NASDAQ: AVGN) is a leader
in the development of gene therapy products to treat serious, chronic
diseases.
EPIX Medical selects R&D
Manage solution to plan and track corporate financials and
resources by project
EPIX Medical, Inc. located in Cambridge, Massachusetts has selected
R&D Logic software solution and services for managing their
corporate and project financials. EPIX Medical (NASDAQ: EPIX)is
a specialty pharmaceutical company and a worldwide leader in the
discovery and development of targeted MRI contrast agents for the
diagnosis and clinical management of disease.
R&D Logic's Customers
Meet Over the Web
In an effort to better serve our customers, R&D Logic organizes
quarterly webinars to discuss topics of common interest. The first
such webinars are beeing held this month to present new features
of the latest product release. Watch for anouncements of future
topics!
BioMedicines selects R&D Manage
solution to budget, forecast and track their financials and project
resources
BioMedicines, Inc. located in Emeryville, California has selected
R&D Logic software solution and services for managing their
corporate and project financials. BioMedicines specializes in developing
and systematically generating new uses for clinical-stag drugs purchased
or licensed from major pharmaceutical companies.
NPS Pharmaceuticals has
selected the R&D Manage solution to support budgeting,
forecasting and tracking of their world wide expenses
NPS Pharmaceuticals, Inc. located in Salt Lake City, Utah has subscribed
to R&D Logic software solution and services. NPS Pharmaceuticals
was founded in 1986 and is engaged in the discovery and development
of novel, small molecule drugs and recombinant peptides that address
a variety of important diseases. With operations in both US and
Canada, NPSP will start using the R&D Manage software by developing
a detailed global budget across the various organizations.
Discovery Partners International
has selected the R&D Manage solution to plan and manage
their consolidated financials
Discovery Partners International, Inc. located in San Diego, California
has subscribed to R&D Logic software solution and services.
Discovery Partners has become a leader in drug discovery collaborations
by offering integrated services and products that span the drug
discovery continuum including target characterization, high throughput
screening, lead generation, lead optimization, high throughput synthesis
automation, and gene expression analysis. With operations in both
US and Europe, DPI will start using the R&D Manage software
by developing a detailed global budget for the entire corporation.
Novacea has opted for the
R&D Manage solution to plan and manage their financials
Novacea, Inc. located in South San Francisco, California has subscribed
to R&D Logic software solution and services. Novacea is a rapidly
growing drug development company that has the exclusive worldwide
rights to the Oregon Health & Science University (OHSU) technology
for dose and a method of use of calcitriol and its analogs, potentially
providing a major breakthrough in the treatment of cancer. R&D
Manage will be first used to create a long range plan of the Company
financials, with an emphasis on clinical trial costs.
Guilford Pharamceuticals has
selected R&D Manage solution to support their objective
driven financial planning and tracking process
Guilford Pharmaceuticals, Inc. located in Baltimore, Maryland has
subscribed to R&D Logic software solution and services. With
implementation efforts already under way, we are looking forward
to integrating the R&D Manage software within a unified platform
for budgeting, forecasting and tracking of the Guilford financials.
CellGate has selected R&D
Manage to support budgeting, forecasting and monthly reporting
activities for their rapidly expanding operations.
CellGate, Inc. located in Sunnyvale, California has subscribed
to R&D Logic software solution and services. CellGate is a pioneer
in the application and development of transporter molecules to deliver
novel medicines into cells and through tissues.
Neurogen (Connecticut) and
Pharmos (New Jersey) have selected R&D Manage to support their
budgeting, forecasting and monthly reporting activities.
NEUROGEN Corporation has acquired a global license for using R&D
Manage software and services. Neurogen is a leader in both the discovery
and development of new drug candidates and in the development and
integration of new drug discovery technologies, most notably its
AIDD (Accelerated Intelligent Drug Discovery) system.
PHARMOS Corporation has subscribed to R&D Manage software and
services. Additionally, R&D Manage will support consolidation
between the Israel and US divisions. Pharmos Corporation is a bio-pharmaceutical
company focused on the discovery, development and commercialization
of therapeutics for the central and peripheral nervous systems,
and ophthalmologic, cardiovascular and inflammation-related indications.
Neurogenetics acquires
global license for using R&D Manage.
NEUROGENETICS, Inc. has subscribed to R&D Manage software and
services. Neurogenetics is a San Diego-based emerging biopharmaceutical
company focused on the development of therapeutics for Alzheimers
disease (AD) and related neurodegenerative disorders, including
Parkinsons disease (PD), Huntingtons disease (HD), stroke,
amyotrophic lateral sclerosis (ALS), epilepsy and chronic pain.
HYSEQ and ZYOMYX have selected
R&D Manage to budget, forecast, track and manage their
R&D operating expenses.
Hyseq, Inc. and Zyomyx have recently subscribed to R&D Manage
software and services. Hyseq, located in Sunnyvale, California,
applies its genomics platform to find and develop biopharmaceuticals
products. Zyomyx, located in Hayward, California, is developing
a new generation of biochips which will enable miniaturized, ultrahigh-throughput
protein analyses to bridge the technology gap in the discovery process
for the biological and life sciences industry.
10 biotech and pharmaceutical
companies are now using our solution for budgeting, forecasting
and tracking.
NeoTherapeutics, Inc. and Metabolex, Inc. have recently joined
our user community. NeoTherapeutics, located in Irvine, California,
is a development-stage biopharmaceutical company engaged in the
discovery and advancement of novel therapeutic agents intended to
treat neurological and psychiatric diseases and conditions. Metabolex
discovers and develops new drugs for type 2 diabetes and brings
to market novel drugs with distinct and complementary modes of action,
to address the full range of defects underlying diabetes. Both companies
will be using R&D Manage on a subscription mode and will first
use the system to create their 2002 budgets.
Valentis, Inc. has subscribed
to R&D Manage.
Valentis, Inc, is taking the discoveries of genomics research and
applying proprietary delivery systems to create therapeutics with
improved safety, efficacy or dosing convenience. Valentis has what
is believed to be the broadest array of technologies and intellectual
property for the delivery of biopharmaceuticals in the industry.
R&D Manage will be integrated with Platinum and the local time
reporting system. The company has centers in three locations: The
Woodlands, Texas, which houses the team focused on preclinical Research
& Development; London, England, where PolyMASC operates as a
wholly-owned subsidiary and focuses on polymer-based delivery; and
Burlingame, California,which is the company headquarters as well
as the center for manufacturing and clinical development. R&D
Manage will be rolled out to the US locations in April 2001.
Intrabiotics has subscribed to R&D Manage.
Intrabiotics Pharmaceuticals Inc, is a biopharmaceutical company
developing novel antibacterial and antifungal drugs for the prevention
or treatment of serious infectious diseases, including those related
to the phenomenon of multi-drug resistant microbes and the infectious
complications of neutropenia. R&D Manage will be integrated
with MAS90 and local time reporting system.
Two new companies have
joined our R&D Manage subscription community in the month of
December, 2000.
Sunesis Pharmaceuticals is applying a revolutionary new approach
to drug discovery that is based on a novel chemical methodology
combined with critical insights into the nature of molecular recognition
between natural macromolecules and their substrates or ligands.
Sunesis will be using R&D Manage and the electronic integration
with Quick Books.
Cytokinetics Inc. is focused on the complementary missions of drug
discovery and the commercialization of novel cellular bioinformatics
technologies. We are excited to integrate R&D Manage with
the General Ledger of Great Plains accounting system.
BioSpace.com has subscribed
to R&D Manage
BioSpace.com, Inc. is the most heavily trafficked business-to-business
life sciences site on the Internet today. The company has selected
R&D Manage as the tool to budget, forecast and track their P&L
by project and by organization. Due to the accelerated implementation
process that has already been kicked-off, BioSpace will be productional
in less then 5 weeks and build their 2001 Budget in R&D Manage.
GeneSoft chooses R&D
Manage over Hyperion
GeneSoft, Inc. a South San Francisco company focused on pharmaceuticals
that modulate gene expression, has subscribed to R&D Manage
with Quick Books for budgeting and tracking of R&D expenses.
Collabra Pharma leases
R&D Manage
Collabra Pharma, Inc., a drug development company based in South
San Francisco, has chosen R&D Manage with Quick Books
to manage their budgeting and tracking of R&D expenses.
|